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The Cre/loxP-system has become the system of choice for the generation of conditional so-called knockout mouse strains, i.e.
the tissue-specific disruption of expression of a certain target gene. We here report the loss of expression of Cre recombinase
in a transgenic mouse strain with increasing number of generations. This eventually led to the complete abrogation of gene
expression of the inserted Cre cDNA while still being detectable at the genomic level. Conversely, loss of Cre expression caused
an incomplete or even complete lack of disruption for the protein under investigation. As Cre expression in the tissue of
interest in most cases cannot be addressed in vivo during the course of a study, our findings implicate the possibility that
individual tail-biopsy genotypes may not necessarily indicate the presence or absence of gene disruption. This indicates that
sustained post hoc analyses in regards to efficacy of disruption for every single study group member may be required.
Citation: Schulz TJ, Glaubitz M, Kuhlow D, Thierbach R, Birringer M, et al (2007) Variable Expression of Cre Recombinase Transgenes Precludes Reliable
Prediction of Tissue-Specific Gene Disruption by Tail-Biopsy Genotyping. PLoS ONE 2(10): e1013. doi:10.1371/journal.pone.0001013
INTRODUCTION
In recent years, the Cre/loxP-system has become the system of
choice for the generation of conditional so-called knockout mouse
strains, i.e. the tissue-specific disruption of expression of a certain
target gene [1,2]. As a body wide, i.e. non-conditional disruption
of single genes frequently leads to premature lethality, conditional
disruption is crucial to investigate the role of a protein by means of
subdivided depletion in closely defined cell types.
Any deliberately chosen DNA sequence can be flanked with
loxP-elements. LoxP-sites are inserted in the intronic spacers of
exons which encode vital structures of the protein of interest. Cre
mediated recombination subsequently leads to the deletion of the
sequence between two loxP-elements and a truncated gene
product if any at all.
Cre recombinase can be expressed in a given tissue or cell type
under the control of a defined promoter fragment. Theoretically,
expression occurs exclusively in the cell type, where the promoter
usually is active [2]. By application of molecular biology methods,
defined parts of the promoter can be linked to the cDNA of Cre
recombinase which then is expressed in the same manner as the
gene it is aimed to replace. Investigators working in this field,
however, have found that Cre expression is often not strictly
confined to the desired cells. Moreover, Cre transgenic mouse
strains tend to display unspecific expression, and thus a knockout
phenotype, in various cell types.
The mechanisms causing these undesired effects are widely
unknown. In the first place, the activity of many promoters in most
cases is not fully understood. Hence, there might be developmental
stages or other environmental factors affecting the activity of
a promoter that have not yet been characterized. When Cre
expression occurs within an early embryonic stage, all cells derived
from this lineage will carry the deleted gene.
Secondly, Cre transgenic mouse strains are mostly generated by
random integration of a DNA construct comprising promoter and
Cre cDNA into the host DNA. This may lead to unspecified
genetic interactions, i.e. transactivations, at the site of integration
which might be concurrently causative for unspecific Cre
expression in many cell types.
Thirdly, a number of articles on the effects of integration site on
the expression pattern of a given transgene have been published.
Termed position-effect variegation (PEV), the phenomenon of mosaic
expression has originally been described as the genetic cause of
heterogeneously coloured eye-discs in mutants of Drosophila
melanogaster [3–5].
Silencing is assumed to be due to site specific effects such as
condensation of chromatin [6,7], close proximity to the centro-
mere [8], transgene orientation and methylation induced silencing
[9]. Furthermore, expression levels of a given transgene appears to
correlate inversely with ageing [10].
These previous publications altogether suggest that various
processes may cause impaired expression of transgenes. We here
demonstrated that this might, at least in some cases, precludes
reliable prediction of tissue-specific gene disruption by tail-biopsy
genotyping.
RESULTS
By means of site directed recombination, mouse models with a liver
specific inactivation of various proteins employing Cre expression
under the control of the Albumin promoter (Alb) have been
generated [11–14]. Specifically for the Alb promoter driven
expression of Cre recombinase, it has been reported, that the
maximum level of recombination in hepatocytes occurs at two
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PLoS ONE | www.plosone.org 1 October 2007 | Issue 10 | e1013weeks of age [15]. We have used this line to generate a liver-
specific knock-out of the frataxin gene [13], and have observed
a unambiguously efficient rate of recombination in our initial
study, i.e. all animals ever analyzed within the initial study group
were bona fide knock-outs. Subsequently and to generate animals
for several follow-up studies we observed inconsistencies between
the phenotype initially observed [13] in comparison to animals
that were derived from intercrosses of later generations carrying
the Alb Cre construct.
Therefore we started to systematically dissect these apparent
inconsistencies. We first analyzed the presence of randomly
integrated Cre transgene by PCR which gives rise to a single
fragment of 387 bp based on previously described primers [16]
derived from the original cDNA sequence of Cre recombinase
(Fig. 1A, columns 1 to 5 and 8 to 9). The presence of a loxP-
flanked exon 4 of the frataxin gene [17] was confirmed by PCR as
previously described [16] and gives rise to either a double band for
heterozygotes (Fig 1B, column 1) or a signal at 545 bp for animals
homozygous for the loxP site (Fig. 1B, columns 2 to 9). In most
laboratories, genotyping of Cre/loxP animals is achieved by PCR
for Cre recombinase and the corresponding loxP-sites, and
considered sufficiently informative while measurement of RNA
expression and/or immunodetection methods for the presence of
disruption is usually performed for a limited number of animals
only. Accordingly, panels A and B of Fig. 1 depict the typical
genotyping result, and would lead to the assumption that column 1
reflects a hemizygous tissue-specific disruption, while columns 2 to
5 and 8 to 9 would indicate the presence of disruption of both
alleles, i.e. a knock-out.
To further evaluate the actual expression of the Cre transgene,
we performed RNA expression analysis. After DNAse digestion
and subsequently performed reverse transcription, cDNA was
subjected to PCR employing the same primers as for detection of
genomic Cre cDNA [16]. While omission of reverse transcription
(Fig. 1C, columns 2 to 9) gave no specific PCR signal indicating
that genomic DNA was absent, RT-PCR of all samples (Fig. 1D)
gave specific signals indicating the presence of Cre recombinase
mRNA in the originating sample for a subset of samples (Fig. 1D,
columns 2, 3, 8, 9) only. This indicates that despite the presence of
a genomic Cre signal (Fig. 1A) some liver specimen did not express
Cre recombinase (Fig. 1D, columns 4 and 5). The imbalance
presented by the misleading genomic Cre signal could be
confirmed by RT-PCR against the targeted exon 4 of the gene
under investigation. Only in those animals, where Cre RNA could
be detected, excision of the fourth exon took place in liver
specimen (Fig. 1E, columns 2, 3 and partially at 8 and 9).
Figure 1. Genotyping and molecular phenotype analysis for hepatocyte specific gene inactivation in the mouse by the Cre/loxP-technique. (a)
Cre-transgene detection by PCR with genomic DNA as template. Columns 0 and 1 depict negative and positive control, respectively (also applies to
subsequent panels B to E). (b) Amplification of genomic DNA for detection of loxP flanked exon 4 of the frataxin gene. A double band depicts
heterozygous genotype (column 1), one band at 545 bp only accordingly indicates homozygous loxP insertion (columns 2 to 9). (c) Control Cre-PCR
from RNA without reverse transcription. (d) RT-PCR of Cre RNA expression. (e) RT-PCR directed at floxed exon 4 of the target gene. The shorter band
stems from RNA with excised exon 4, the long band corresponds to the intact loxP flanked exon 4. (f) Immunodetection of Cre/loxP-targeted frataxin
expression in the liver. (g) Ponceau staining of membrane before immunodetection to ensure equal loading of protein in all columns.
doi:10.1371/journal.pone.0001013.g001
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a partial retention of the intact target gene (Fig. 1E, columns 8 and
9). This finding might correlate with the level of Cre expression, as
in these latter animals, signals derived from Cre RT-PCR were
found to be weak (Fig. 1D, columns 8 and 9).
To further extend our findings in regards to the lack of
expression of Cre in certain animals, we performed Western blot
analyses to assess hepatic expression levels of the targeted protein,
frataxin. In those animals which showed Cre transcription and
complete target gene truncation, the knockout was detectable and
complete on a translational level (Fig. 1F, columns 2 and 3).
However, concurrent with the lack of Cre mRNA, we found
a normal expression of frataxin protein in those animals that
where genotyped as knockouts, but had no Cre expression or
truncation of the target gene-RNA (Fig. 1F, columns 4 and 5).
More surprisingly, we found a complete lack for the expression of
the targeted protein in one of the animals with incompletely
truncated RNA (Fig. 1F column 9), while the other apparently had
no reduction in protein expression at all (Fig. 1F, column 8) despite
the fact that no gross differences in regards to Cre (Fig. 1D) and
frataxin (Fig. 1E) transcripts were detectable.
DISCUSSION
Our current findings suggest the possible involvement of several
distinct mechanisms, which lead to the observed silencing of
transgene expression. Since the Cre cDNA has been randomly
integrated into the genomic DNA [11], it is likely that not all copies
integrated into the genome have the same transcriptional activity.
This might be due to various silencing effects of the neighbouring
DNA-sequences. One possible model to explain the apparently
contradictory findings would include the event of homologous
recombination of the transgene flanking regions, in which inactive
copies of the transgene segregate from those still active. This process
could be a result of multiple recombination events throughout
a number of consecutive generations, i.e. breeding. As a conse-
quence, the inactive copy of the transgene could still be detected by
genomicPCR whilenoexpression ofthe transgene wouldtakeplace.
Recently, in the model organism Drosophila melanogaster, it has
been proposed, that the Argonaute proteins AGO1 und AGO2
play a central role in post-transcriptional silencing [18]. Taking
into account the conflicting phenotypes in some animals with only
partial recombination of the target gene (Fig.1, panels E and F,
columns 8 and 9), our data tentatively suggest, that transcript
degradation could at least play a possible role in silencing
expression of Cre recombinase.
From retrovirus-mediated transgene expression it is known that
methylation of the long terminal repeat region takes place.
Furthermore, binding of transcriptional inhibitors to responsive
elements in the transgenic construct results in reduced expression
of the transgene [19–21]. This tentatively indicates the possibility
of silencing mechanisms acting in parallel on genetic and
transcriptional levels.
Taken together, the data presented here indicate that, although
misleadingly being detectable at a genomic level, expression of the
Cre transgene may be completely abolished in a subset of mice.
Further experiments will be required to elucidate the mechanism(s)
responsible for these effects. These findings highlight the
importance of sustained and comprehensive monitoring of the
presence of disruption on a transcriptional or translational level for
tissue-specific knock-out models.
MATERIALS AND METHODS
Maintenance and genotyping of animals
Animals were generated [17] and maintained [16] as previously
described.
Nucleic acid isolation and amplification
Isolation of genomic DNA and RNA was performed as previously
described [16]. Amplification of genomic DNA and reversely
transcribed RNA was performed as described [16] except that
newly isolated RNA was digested with DNAse I (Roche, Basel,
Switzerland) and the restriction enzyme AluI (Roche), an enzyme
additionally used to ensure complete removal of contaminating
genomic DNA. Subsequently, samples were loaded onto a column
to separate RNA from enzyme and digestion buffer (RNeasy
Cleanup Kit, Qiagen, Weiden, Germany).
Protein Extraction and Immunodetection
Protein samples were prepared as described [22]. For SDS-PAGE,
50 mg of denatured protein-lysate was loaded on each lane of
a 16% gel. Separation of proteins and frataxin expression analysis
were performed as described previously [22] with a polyclonal
antibody directed against mouse frataxin [17].
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